Home Overview Press Room Blog Publications For Students about us
Search

Personal genomics : Displaying 200-219 of 614


Henrietta Lacks' Genes and All of Yours?by Robert KlitzmanHuffington PostSeptember 2nd, 2013A woman whose son was born with a severe disease agreed to have her genes examined to help find the cause, but struggled to decide whether to learn lots of other information about her and her family.
Amici Submit Brief in Support of Ambry Genetics and Gene by Geneby Donald ZuhnPatent DocsAugust 27th, 2013The American Civil Liberties Union, Breast Cancer Action, and several others submitted an amici curiae brief in two infringement actions brought by Myriad Genetics.
New Prenatal Tests Provide More Information, but Link to Problems Isn’t Clearby Lea WinermanWashington PostAugust 26th, 2013Microarray testing is now routinely offered to expectant parents when karyotyping fails to find a genetic cause for problems identified by ultrasound.
Are You Ready for an Online Genetic Test?[WITH VIDEOS]by Dr. Barry StarrKQEDAugust 26th, 2013For the right person, an online genetic test can be both fun and useful. But for someone else, it might be overwhelming. Or even worse, reveal things they wish they hadn’t learned.
Corporate Geneticsby Robert NussbaumTechnology ReviewAugust 21st, 2013In June the U.S. Supreme Court ruled that patents on genes were invalid. Yet corporate intellectual-property claims can still harm patients.
Rich Nations not Collaborating in Genomics for Public Health, Says OECD by Lynne TaylorPharmaTimesAugust 19th, 2013New reports show that the development of genomics for public health is being prioritised mainly by low and middle income nations, with richer countries not seeking to collaborate in such research.
Unhidden Traits: Genomic Data Privacy Debates Heat Upby Abdul-Kareem AhmedScientific AmericanAugust 14th, 2013We shield social security numbers, conceal credit cards and shred sensitive records. Now it's time to think about how closely we guard our genomes.
Would you Post your DNA on Facebook?by Quentin FottrellThe Wall Street JournalAugust 12th, 2013We are all Henrietta Lacks. Or, according to privacy experts, we soon could be. Americans are giving their DNA to companies without thinking through the potential long-term consequences.
Why Is Myriad Genetics Still Filing Patent Suits for Breast-Cancer Tests?by Brian ResnickNational JournalAugust 8th, 2013Why did Myriad Genetics sue a competitor for testing for the very gene recently declared unpatentable by the Supreme Court?
23andMe, Myself, and Iby Nathaniel ComfortGenotopiaAugust 7th, 201323andMe's new ad will begin airing shortly on cable TV, and it's all about "me."
Edge of the Map: An Experiment in Science and in Theaterby Alice WexlerUCLA Center for the Study of WomenAugust 6th, 2013A group of Harvard students created a theater piece called Edge of the Map, a collage based on real-life and invented scenarios involving ethical and social dilemmas in genetics.
If I'm Healthy, Why Should I Have my Genome Sequenced?by Anne Buchanan et al.The Mermaid's TaleAugust 6th, 2013Do people believe that future disease is truly predictable from their genome? We think that most geneticists, at least, would say not.
DTC Monopoly and Meby Jessica CussinsBiopolitical TimesAugust 6th, 2013A recent study shows yet again that results from different direct-to-consumer genetic testing companies vary. So what will the emerging monopoly of 23andMe mean for accuracy?
The Biggest Threat to the Genomic Revolution? Spying Scandals by Gillian TettFinancial TimesJuly 31st, 2013It is now possible for scientists to compare the genomic sequence of thousands of people and thus spot patterns of diseases that range from cancer to schizophrenia, but what about privacy?
Science as Social Control: Political Paralysis and the Genetics Agendaby Jonathan LathamIndependent Science NewsJuly 31st, 2013A new study in Science found that fully 98% of variation in “educational attainment” cannot be attributed to inherited genetic differences. Why did the authors fail to mention this fact in the title or in the summary?
uBiome: Ethical Lapse or Not?by Judy StoneScientific AmericanJuly 25th, 2013Skirting the rules hurts the company's image, fosters mistrust and, perhaps more importantly, may hurt the citizen science movement more broadly.
Made With Loveby Jessica CussinsBiopolitical TimesJuly 22nd, 2013The first baby has been born following “next generation genetic sequencing” of IVF embryos. What are the implications?
Genetic Screening: Every Newborn a Patientby Stefan TimmermansLos Angeles TimesJuly 19th, 2013Giving parents a torrent of information about a child's genetic disease risk will profoundly change the experience of bringing a new life into the world.
Direct-To-Consumer Genetic Testing Kits Vary in Predictions of Disease RiskMedical XpressJuly 17th, 2013An in-depth analysis and comparison showed that predicted risks differed among the companies and were contradictory for certain traits in certain individuals.
Senator Leahy Urges NIH to Use March-In Rights on Myriad BRCA Testby Donald ZuhnPatent DocsJuly 17th, 2013The government can ensure greater access to genetic testing for breast and ovarian cancer, under a law that protects taxpayers from having to pay for inventions the public has already funded.
Displaying 200-219 of 614  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760